| Abstract |
The invention concerns vaccines and the use of the naked DNA and/or RNA molecule encoding hemagglutinin (HA) from pandemic influenza, e.g. the 1918 HlNl and/or the 1957 H2N2 and/or the 1968 H3N2 influenza A virus and/or the high pathogenic bird pandemic ATV strain (A/buzzard/Denmark/6370/06(H5Nl)) and/or 2001 H5N7 low pathogenic Avian influenza virus (ATV) strain (A/Mallard/Denmark/64650/03(H5N7)) or the March 2006 Denmark H5N1 high pathogenic AIV strain (A/buzzard/Denmark/6370/06(H5Nl)) or the 2008 (A/duck/Denmark/53- 147-8/08 (H7N1)) or the 2004 (A/widegeon/Denmark/66174/G18/04 (H2N3)) as a vaccine component against present day and coming Hl, H2, H3, H5, |